A Single and Multiple Ascending Dose Study of CK-3828136 in Healthy Adult Participants

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Healthy Participants

In brief

1. Learn about the safety and tolerability of CK-3828136 after a single dose and multiple doses in healthy subjects. 2. Find out how much CK-3828136 is in the blood after a single dose and multiple doses. 3. Determine the effect different doses of CK-3828136 on the pumping function of the heart.

Key facts

Study ID
NCT05662215
Run by
Cytokinetics
People needed
57
Starts
2022-12-06
Expected to finish
2023-08-08
Last updated by the study team
2024-10-17

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.